BCL6 and COVID-19: Kaneko et al. [17] provided a mechanistic explanation for the limited durability of antibody responses in individuals with SARS-CoV-2 infections, hypothesizing that this was related to the loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 patients.